Skip to main content
. 2018 Mar 27;18:352. doi: 10.1186/s12885-018-4223-y

Table 3.

Incidence of grade ≥ 3 adverse events

Grade ≥ 3 adverse events Afatinib (%) Pemetrexed-cisplatin (%)
Neutropenia 0.4 18.0
Fatigue 1.3 12.6
Anaemia 0.4 6.3
Nausea 0.9 3.6
Diarrhoea 14.4 0.0
Rash 16.2 0.0
Vomiting 3.1 2.7

Source: Sequist et al, [6]